TrialNature2020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Mark J Mulligan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
900 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialNature2020
Mark J Mulligan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.